Estrella Immunopharma (ESLA) Payables (2021 - 2026)
Estrella Immunopharma (ESLA) posted quarterly Payables of $480079.0 for Q1 2026, up 3332.08% year-over-year from $13988.0 in Q1 2025, and down 43.95% quarter-over-quarter from $856505.0 in Q4 2025.
Estrella Immunopharma (ESLA) Payables (2021 - 2026) Analysis & Trends
Estrella Immunopharma (ESLA) has reported Payables for 6 consecutive years, with $480079.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables rose 3332.08% year-over-year to $480079.0; the TTM figure through Mar 2026 stood at $480079.0 (up 3332.08% YoY), while the FY2025 annual figure was $856505.0, up 19212.4% from the prior year.
- Payables eased to $480079.0 in Q1 2026 per ESLA's latest filing, from $856505.0 in the prior quarter.
- Across five years, Payables topped out at $9.6 million in Q3 2023 and bottomed at $4435.0 in Q4 2024.
- Historically, Payables has averaged $1.5 million across 5 years, with a median of $329166.0 in 2022.
- Annual changes were most pronounced in 2022 — Payables surged 23403.2% — and 2024, when it tumbled 99.95%.
- Estrella Immunopharma's Payables stood at $329166.0 in 2022, then sank by 76.58% to $77076.0 in 2023, then sank by 94.25% to $4435.0 in 2024, then jumped by 19212.4% to $856505.0 in 2025, then tumbled by 43.95% to $480079.0 in 2026.
- Business Quant data shows ESLA's Payables at $480079.0 in Q1 2026, $856505.0 in Q4 2025, and $390986.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | Estrella Immunopharma | 32.24 Mn | 32.10 Mn | - | 695,456.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 695,456.00 |
| Mar 31, 2026 | 480,079.00 |
| Dec 31, 2025 | 856,505.00 |
| Sep 30, 2025 | 390,986.00 |
| Jun 30, 2025 | 196,095.00 |
| Mar 31, 2025 | 13,988.00 |
| Dec 31, 2024 | 4,435.00 |
| Sep 30, 2024 | 5,000.00 |
| Dec 31, 2023 | 77,076.00 |
| Sep 30, 2023 | 9.64 Mn |
| Jun 30, 2023 | 9.61 Mn |
| Mar 31, 2023 | 511,534.00 |
| Dec 31, 2022 | 329,166.00 |
| Sep 30, 2022 | 705,096.00 |
| Jun 30, 2022 | 106,447.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |